Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06341894
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-02-24
Brief Title:
Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR HER2- Early Breast Cancer
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Organization Data
Organization:
The First Affiliated Hospital with Nanjing Medical University
Class:
OTHER
Study ID:
OBU-II-BC-126
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Liu Xiaoan
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital with Nanjing Medical University
Old Name:
None
Old Organization:
None